These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32324420)

  • 1. Enhancing Safety and Efficacy by Altering the Toxic Aggregated State of Amphotericin B in Lipidic Nanoformulations.
    Das S; Devarajan PV
    Mol Pharm; 2020 Jun; 17(6):2186-2195. PubMed ID: 32324420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations.
    Todke PA; Devarajan PV
    J Control Release; 2022 Sep; 349():756-764. PubMed ID: 35905782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Platform Comparison of Polymeric and Lipidic Nanoparticles for the Delivery of Amphotericin B.
    Joyson N; Pathak A; Jain K
    AAPS PharmSciTech; 2023 Nov; 24(8):226. PubMed ID: 37945925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
    Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
    Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
    Jansook P; Fülöp Z; Ritthidej GC
    Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Antileishmanial Activity Employing Conventional and Solid Lipid Nanoparticles of Amphotericin B on Leishmania major In Vitro and In Vivo.
    Soltani S; Mojiri-Forushani H; Soltani S; Kahvaz MS; Foroutan M
    Infect Disord Drug Targets; 2020; 20(6):822-827. PubMed ID: 31613731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis.
    Caldeira LR; Fernandes FR; Costa DF; Frézard F; Afonso LC; Ferreira LA
    Eur J Pharm Sci; 2015 Apr; 70():125-31. PubMed ID: 25660615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis.
    Silva-Carvalho R; Fidalgo J; Melo KR; Queiroz MF; Leal S; Rocha HA; Cruz T; Parpot P; Tomás AM; Gama M
    Int J Biol Macromol; 2020 Jun; 153():276-288. PubMed ID: 32145228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity.
    Kumar P; Shivam P; Mandal S; Prasanna P; Kumar S; Prasad SR; Kumar A; Das P; Ali V; Singh SK; Mandal D
    Int J Nanomedicine; 2019; 14():6073-6101. PubMed ID: 31686803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis.
    Parvez S; Yadagiri G; Gedda MR; Singh A; Singh OP; Verma A; Sundar S; Mudavath SL
    Sci Rep; 2020 Jul; 10(1):12243. PubMed ID: 32699361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.
    Jansook P; Pichayakorn W; Ritthidej GC
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system.
    Singh A; Yadagiri G; Negi M; Kushwaha AK; Singh OP; Sundar S; Mudavath SL
    Int J Biol Macromol; 2022 Apr; 204():373-385. PubMed ID: 35149096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid carrier system.
    Parvez S; Yadagiri G; Singh A; Karole A; Singh OP; Sundar S; Mudavath SL
    Chem Phys Lipids; 2020 Sep; 231():104946. PubMed ID: 32621810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsions Loaded with Amphotericin B: Development, Characterization and Leishmanicidal Activity.
    Araújo GMF; Barros ARA; Oshiro-Junior JA; Soares LF; da Rocha LG; de Lima ÁAN; da Silva JA; Converti A; Damasceno BPGL
    Curr Pharm Des; 2019; 25(14):1616-1622. PubMed ID: 31298163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: A novel green approach.
    Ahmad A; Wei Y; Syed F; Khan S; Khan GM; Tahir K; Khan AU; Raza M; Khan FU; Yuan Q
    J Photochem Photobiol B; 2016 Aug; 161():17-24. PubMed ID: 27203567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa.
    Attar ES; Jayakumar S; Devarajan PV
    AAPS PharmSciTech; 2024 May; 25(5):113. PubMed ID: 38750336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.